Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,876.00    -30.00 (-1.03%)
Bid:
2,872.00
Ask:
2,878.00
Spread: 6.00 (0.209%)
Market Cap: £1.58b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Trading Update

18 Mar 2020 07:00

RNS Number : 5358G
Oxford Instruments PLC
18 March 2020
 

 

Oxford Instruments plc

Trading Update 18 March 2020

 

Oxford Instruments plc, a leading provider of high technology products and services to industrial companies and scientific research communities, is today issuing a trading update.

 

Given the current uncertainty from Covid-19 and the impact on trading, Oxford Instruments plc is issuing its pre-close for the financial year 2019/20 earlier than usual.

 

The severe disruption as a result of Covid-19 has impacted our customers, with a number of product shipments and installations in the final quarter of the financial year being delayed, in addition to an enforced site closure in California. While we are seeing some re-opening of customer sites in China, the situation in Europe and North America is deteriorating. As a result, the Group currently expects adjusted operating profit for the full year of between £47m to £50m.

 

Looking ahead, we expect current events to adversely impact trading during the first half of the financial year 2020/21, but at this stage there remains considerable uncertainty. The Group has a strong balance sheet and substantial liquidity, with net cash of over £50m. We operate in robust markets with a well-positioned portfolio of products and solutions for attractive end markets. We remain committed to our strategy and would expect trading to recover in line with a reduction in disruption from Covid-19.

 

Oxford Instruments' results for the year ended 31 March 2020 will be released on 9 June 2020.

 

Note: Oxford Instruments compiled consensus analyst forecast for adjusted operating profit (year to 31 March 2020) is £53.3m. This excludes analysts that have not updated forecasts following the disposals of OI Healthcare and our share in Scienta Omicron.

 

 

 

 

Enquiries:

 

Oxford Instruments plc Tel: 01865 393200

Ian Barkshire, Chief Executive

Gavin Hill, Group Finance Director

 

MHP Communications Tel: 020 3128 8100

Rachel Hirst/Alice McLaren

 

 

 

- Ends -

Issued for and on behalf of Oxford Instruments plc

Notes to Editors  

 

About Oxford Instruments plc

 

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for 60 years, supporting its core purpose to address some of the world's most pressing challenges. 

 

The first technology business to be spun out from Oxford University, Oxford Instruments is now a global company and is listed on the FTSE250 index of the London Stock Exchange (OXIG). Its strategy focuses on being a customer-centric, market-focused Group, understanding the technical and commercial challenges faced by its customers. Key market segments include Semiconductor & Communications, Advanced Materials, Healthcare & Life Science, and Quantum Technology.

 

Their portfolio includes a range of core technologies in areas such as low temperature and high magnetic field environments; Nuclear Magnetic Resonance; X-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; and advanced growth, deposition and etching.

 

Oxford Instruments is helping enable a greener economy, increased connectivity, improved health and leaps in scientific understanding. Their advanced products and services allow the world's leading industrial companies and scientific research communities to image, analyse and manipulate materials down to the atomic and molecular level, helping to accelerate R&D, increase manufacturing productivity and make ground-breaking discoveries.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKOBKKBKBFND
Date   Source Headline
17th Apr 20251:40 pmPRNHolding(s) in Company
16th Apr 20257:00 amRNSTrading Update
15th Apr 20251:30 pmPRNHolding(s) in Company
14th Apr 20253:33 pmPRNDirector/PDMR Shareholding
10th Apr 20257:00 amRNSHolding(s) in Company
1st Apr 20257:00 amRNSTotal Voting Rights
25th Mar 202512:35 pmPRNHolding(s) in Company
24th Mar 20252:35 pmPRNHolding(s) in Company
7th Mar 20259:00 amPRNHolding(s) in Company
6th Mar 20258:30 amPRNHolding(s) in Company
5th Mar 202511:37 amPRNHolding(s) in Company
5th Mar 202510:40 amPRNDirector/PDMR Shareholding
3rd Mar 202510:59 amPRNTotal Voting Rights
17th Feb 20258:52 amPRNDirectorate Change
10th Feb 20253:26 pmPRNDirector/PDMR Shareholding
3rd Feb 20251:30 pmPRNTotal Voting Rights
13th Jan 202511:09 amPRNDirector/PDMR Shareholding
9th Jan 20257:00 amRNSChief Financial Officer succession
7th Jan 20254:48 pmPRNDirector Declaration
3rd Jan 202511:39 amPRNBlocklisting - Interim Review
2nd Jan 202511:38 amPRNTotal Voting Rights
13th Dec 202412:15 pmRNSHolding(s) in Company
12th Dec 20243:41 pmRNSDirector/PDMR Shareholding
2nd Dec 202411:00 amPRNTotal Voting Rights
12th Nov 202412:30 pmPRNDirector/PDMR Shareholding
12th Nov 20247:00 amRNSHalf-Year Results
8th Nov 202411:54 amPRNHolding(s) in Company
23rd Oct 20242:30 pmPRNHolding(s) in Company
16th Oct 20247:00 amRNSHalf Year Trading Update
14th Oct 20248:54 amPRNDirector/PDMR Shareholding
1st Oct 202411:31 amPRNTotal Voting Rights
11th Sep 20243:48 pmPRNDirector/PDMR Shareholding
2nd Sep 20248:39 amPRNTotal Voting Rights
14th Aug 20249:09 amPRNDirector/PDMR Shareholding
12th Aug 20244:37 pmPRNDirector/PDMR Shareholding
9th Aug 20241:15 pmPRNDirector/PDMR Shareholding
1st Aug 202410:57 amPRNTotal Voting Rights
26th Jul 20249:59 amPRNAnnual General Meeting 2024 Results
25th Jul 20249:31 amPRNDirector/PDMR Shareholding
24th Jul 20249:00 amPRNDirector Declaration
23rd Jul 20244:00 pmPRNDirector/PDMR Shareholding
18th Jul 20244:32 pmPRNHolding(s) in Company
18th Jul 20244:29 pmPRNHolding(s) in Company
18th Jul 20248:00 amPRNBlock Listing Application
12th Jul 20241:04 pmPRNHolding(s) in Company
12th Jul 202410:05 amPRNDirector/PDMR Shareholding
2nd Jul 20242:11 pmPRNBlocklisting - Interim Review
1st Jul 202412:21 pmPRNTotal Voting Rights
1st Jul 20249:14 amRNSCompletion of acquisition of FemtoTools AG
25th Jun 202412:51 pmPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.